News | May 22, 2023
Eris Lifesciences posts consolidated Q4FY23 PAT at Rs. 65.41 Cr
Eris Lifesciences has reported total income of Rs. 403.80 crores during the period ended March 31, 2023
Eris Lifesciences has reported total income of Rs. 403.80 crores during the period ended March 31, 2023
The company has reported total income of Rs. 815.11 crores during the period ended March 31, 2023
8th Edition of the event to promote India as a manufacturing hub of quality medical products in the Pharmaceutical and Medical Devices Sector
The company has reported total income of Rs. 1392.72 crores during the period ended March 31, 2023
The company has reported total income of Rs. 2971.27 crores during the period ended March 31, 2023
The company has reported total income of Rs. 580.81 crores during the period ended March 31, 2023
Gland Pharma has reported total income of Rs. 823.95 crores during the period ended March 31, 2023
The company has reported total income of Rs. 604.02 crores during the period ended March 31, 2023
The company has reported total income of Rs. 149.78 crores during the period ended March 31, 2023
Dr. Lal Path Labs has reported total income of Rs. 505.2 crores during the period ended March 31, 2023
Subscribe To Our Newsletter & Stay Updated
